Multiscale modeling and simulation of nano‐carriers delivery through biological barriers—a review

X Shi, F Tian - Advanced Theory and Simulations, 2019 - Wiley Online Library
The past several decades have witnessed the explosion of nanomedicine for cancer
therapy, where notable research efforts have been made in synthesizing and delivering …

Processing chitosan for preparing chitosan-functionalized nanoparticles by polyelectrolyte adsorption

BK Wilson, RK Prud'homme - Langmuir, 2021 - ACS Publications
Chitosan-coated nanoparticles are a promising class of drug delivery vehicles that have
been studied as tools for improving the gastrointestinal delivery of therapeutics. Here we …

Preparation and characterization of tetrandrine-phospholipid complex loaded lipid nanocapsules as potential oral carriers

Y Zhao, L Wang, C Ma, K Zhao, Y Liu… - International journal of …, 2013 - Taylor & Francis
Background Tetrandrine is an active constituent that is extracted from the root tuber of the
Chinese herb Stephania tetrandra S. Moore. It has shown various pharmacological effects …

Loratadine self-microemulsifying drug delivery systems (SMEDDS) in combination with sulforaphane for the synergistic chemoprevention of pancreatic cancer

P Desai, A Thakkar, D Ann, J Wang… - Drug delivery and …, 2019 - Springer
Pancreatic cancer (PC), currently the third leading cause of cancer-related deaths in the
USA, is projected to become the second leading cause, behind lung cancer, by 2020. The …

Nanomedicines for oral administration based on diverse nanoplatform

T Sim, C Lim, NH Hoang, H Joo, JW Lee, D Kim… - Journal of …, 2016 - Springer
Nanotechnology has been applied to the oral drug delivery for enhancing bioavailability
after oral administration. Numerous forms of reported nanomedicines are classified as lipid …

Pharmacokinetics and biodistribution of the nanoparticles

K Raza, P Kumar, N Kumar, R Malik - … in nanomedicine for the delivery of …, 2017 - Elsevier
Nanotechnology is an emerging and promising technique, giving pavement to a novel
therapeutic domain, ie, nanomedicine. The drug molecules in nanomedicine are the same …

Preparation and comparison of oral bioavailability for different nano-formulations of olaparib

AD Pathade, N Kommineni, U Bulbake… - AAPS …, 2019 - Springer
Olaparib (OLA) is a poly ADP ribose polymerase (PARP) inhibitor approved for germline
BRCA-mutated (gBRCAm) advanced ovarian cancer and breast cancer. Low oral …

[HTML][HTML] Exploring the solvent-anti-solvent method of nanosuspension for enhanced oral bioavailability of lovastatin

AS Patil, R Hegde, AP Gadad, PM Dandagi… - Turkish Journal of …, 2021 - ncbi.nlm.nih.gov
Objectives: Lovastatin is an antilipidemic drug that belongs to the class of statins that has
poor oral bioavailability due to its low solubility and variable dissolution rate. The main aim …

P-gp inhibition-based strategies for modulating pharmacokinetics of anticancer drugs: an update

X Yang, K Liu - Current drug metabolism, 2016 - ingentaconnect.com
Background: P-glycoprotein (P-gp), a well known ATP dependent efflux membrane
transporter, has been attracting considerable interests of medical researchers due to its …

Optimized zein nanospheres for improved oral bioavailability of atorvastatin

FM Hashem, MM Al-Sawahli, M Nasr… - International journal of …, 2015 - Taylor & Francis
Background This work focuses on the development of atorvastatin utilizing zein, a natural,
safe, and biocompatible polymer, as a nanosized formulation in order to overcome the poor …